ad image

Nice Insight

1 / 10
From Chemo to Advanced Therapies: New Frontiers in Oncology
Oncology

From Chemo to Advanced Therapies: New Frontiers in Oncology

Serene Lee

Nice Insight

PAO-25-30-29Apr 15, 2025
Gene Therapy at 30: Milestones, Setbacks, and a Path Forward
Gene Therapy

Gene Therapy at 30: Milestones, Setbacks, and a Path Forward

Cynthia A. Challener, Ph.D.

Pharma's Almanac

PAO-25-30-28Apr 14, 2025
Breaking New Ground: 30 Years of First-in-Class Drug Innovation
First-in-Class Drugs

Breaking New Ground: 30 Years of First-in-Class Drug Innovation

Cynthia A. Challener, Ph.D.

Pharma's Almanac

PAO-25-30-27Apr 09, 2025
Building Resilient Pharma Supply Chains in an Uncertain World
Supply Chain

Building Resilient Pharma Supply Chains in an Uncertain World

Cynthia A. Challener, Ph.D.

Pharma's Almanac

PAO-25-30-26Mar 31, 2025
Expanding the Frontiers of Cell Therapy: Veterinary Applications and Translational Insights
Cell Therapy

Expanding the Frontiers of Cell Therapy: Veterinary Applications and Translational Insights

April Stanley, MS MBA; Sophie Lutter, Ph.D.

Nice Insight

PAO-03-25-NI-07Mar 26, 2025
Is mRNA a Gene Therapy? Unpacking the Evolving Regulatory Debate
RNA

Is mRNA a Gene Therapy? Unpacking the Evolving Regulatory Debate

Cynthia A. Challener, Ph.D.; April Stanley, MS MBA

Pharma's Almanac

PAO-03-25-NI-06Mar 26, 2025
From Niche to Necessity: How Single-Use Transformed Biomanufacturing
SUT

From Niche to Necessity: How Single-Use Transformed Biomanufacturing

Cynthia A. Challener, Ph.D.

Pharma's Almanac

PAO-25-30-25Mar 24, 2025
Beyond mRNA Vaccines: The Expanding World of RNA-Based Therapeutics
RNA

Beyond mRNA Vaccines: The Expanding World of RNA-Based Therapeutics

David Alvaro, Ph.D.

Pharma's Almanac

PAO-25-30-24Mar 21, 2025
Genomics and the Next Era of Precision Medicine
Genomics

Genomics and the Next Era of Precision Medicine

David Alvaro, Ph.D.

Pharma's Almanac

PAO-25-30-23Mar 20, 2025
Resetting the Biological Clock: OKSM and the Reversal of Aging
Aging

Resetting the Biological Clock: OKSM and the Reversal of Aging

David Alvaro, Ph.D.

Pharma's Almanac

PAO-25-30-22Mar 19, 2025
Clinical Trials Without Borders: The Evolution of Global Drug Development
Global Trials

Clinical Trials Without Borders: The Evolution of Global Drug Development

David Alvaro, Ph.D.

Pharma's Almanac

PAO-25-30-21Mar 14, 2025
Boolean Biology: The Future of Logic-Gated Cell and Gene Therapies
LOGIC GATES

Boolean Biology: The Future of Logic-Gated Cell and Gene Therapies

David Alvaro, Ph.D.

Pharma's Almanac

PAO-03-25-NI-03Mar 14, 2025
The Final Frontier: Biomanufacturing in Space
Space

The Final Frontier: Biomanufacturing in Space

David Alvaro, Ph.D.

Pharma's Almanac

PAO-25-30-20Mar 13, 2025
From Patients to Partners: The Rising Power of Advocacy in Drug Development
Advocacy

From Patients to Partners: The Rising Power of Advocacy in Drug Development

David Alvaro, Ph.D.

Pharma's Almanac

PAO-25-30-19Mar 13, 2025
Accelerating Patient Access Through Decentralized Clinical Trials
DCTs

Accelerating Patient Access Through Decentralized Clinical Trials

Cynthia A. Challener, Ph.D.

Pharma's Almanac

PAO-25-30-18Mar 12, 2025
Global Health at a Crossroads and the Future of Pandemic Preparedness
Pandemic

Global Health at a Crossroads and the Future of Pandemic Preparedness

David Alvaro, Ph.D.

Pharma's Almanac

PAO-25-30-17Mar 12, 2025
The Biomarker Revolution in Medicine and Drug Development
Biomarkers

The Biomarker Revolution in Medicine and Drug Development

David Alvaro, Ph.D.

Pharma's Almanac

PAO-25-30-16Mar 10, 2025
Working Toward a Future Without Neglected Tropical Diseases
NTDs

Working Toward a Future Without Neglected Tropical Diseases

Serene Lee

Nice Insight

PAO-25-30-15Mar 07, 2025
Fighting for Diversity and Equity in Pharma and Biopharma
Diversity

Fighting for Diversity and Equity in Pharma and Biopharma

David Alvaro, Ph.D.

Pharma's Almanac

PAO-25-30-05Mar 06, 2025
Three Decades of Collaboration: Evolution from Basic Partnerships to Complex Open-Innovation Models
Collaboration

Three Decades of Collaboration: Evolution from Basic Partnerships to Complex Open-Innovation Models

Cynthia A. Challener, Ph.D.

Pharma's Almanac

PAO-25-30-14Mar 03, 2025
1 / 10